These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 9514533)

  • 1. Effects of the endothelin receptor antagonist TAK-044 on hepatocyte element alterations in the ischemic-reperfused liver in Beagle dogs.
    Imakita M; Yamanaka N; Kuroda N; Kitayama Y; Sasaki S; Nakagaki I; Hori S; Okamoto E
    J Hepatol; 1998 Feb; 28(2):204-11. PubMed ID: 9514533
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hepatoprotective effect of the endothelin receptor antagonist TAK-044 against ischemia-reperfusion injury in the canine liver.
    Kitayama Y; Yamanaka N; Kawamura E; Kuroda N; Okamoto E
    Hepatology; 1997 Apr; 25(4):938-42. PubMed ID: 9096601
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hepatoprotective effect of a nonselective endothelin receptor antagonist (TAK-044) in the transplanted liver.
    Yamanaka N; Takaya Y; Oriyama T; Furukawa K; Tanaka T; Tanaka W; Ichikawa N; Yasui C; Ando T; Yamanaka J; Kuroda N; Ko M; Takada M; Imakita M; Kitayama Y; Okamoto E; Sasaki S; Nakagaki I; Hori S; Ito T
    J Surg Res; 1997 Jul; 70(2):156-60. PubMed ID: 9245565
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In vivo subcellular elemental dynamics in liver graft: With special reference to effect of non-selective endothelin receptor antagonist, TAK-044, on the graft injury.
    Takaya Y; Yamanaka N; Oriyama T; Furukawa K; Tanaka T; Nakagaki I; Sasaki S; Hori S; Okamoto E
    Hepatol Res; 2000 Nov; 18(3):171-183. PubMed ID: 11058822
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Optimal route of administration of mixed endothelin receptor antagonist (TAK-044) in liver transplantation.
    Tanaka W; Yamanaka N; Onishi M; Ko M; Yamanaka J; Okamoto E
    J Gastroenterol; 2000; 35(2):120-6. PubMed ID: 10680667
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of an endothelin receptor antagonist TAK-044 on myocardial energy metabolism in ischemia/reperfused rat hearts.
    Iimuro M; Kaneko M; Matsumoto Y; Fujise Y; Watanabe T; Hayashi H
    J Cardiovasc Pharmacol; 2000 Mar; 35(3):403-9. PubMed ID: 10710125
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of non-selective endothelin blockade, TAK-044, on the ischemic cellular injury of rat heart.
    Geshi E; Nomizo A; Arata Y; Nakatani M; Katagiri T
    Basic Res Cardiol; 1999 Apr; 94(2):94-101. PubMed ID: 10326657
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Endothelin in liver cell injury and regeneration after 70% hepatectomy with portal ischemia.
    Kitamura Y; Usami M; Kotani G; Iso A; Sen H; Tagawa Y; Kasahara H; Yamamoto M; Saitoh Y
    J Cardiovasc Pharmacol; 1998; 31 Suppl 1():S480-1. PubMed ID: 9595518
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of a new endothelin receptor antagonist, TAK-044, on myocardial stunning in dogs.
    Kitayoshi T; Ikeda S; Kubo K; Awane-Igata Y; Watanabe T; Fujino M
    Eur J Pharmacol; 1996 Jun; 305(1-3):137-43. PubMed ID: 8813544
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Does topical cooling alleviate ischemia/reperfusion injury during inflow occlusion in hepatectomy? Results of an experimental and clinical study.
    Imakita M; Yamanaka N; Kuroda N; Kitayama Y; Okamoto E
    Surg Today; 2000; 30(9):795-804. PubMed ID: 11039707
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of a new endothelin antagonist, TAK-044, on post-ischemic acute renal failure in rats.
    Kusumoto K; Kubo K; Kandori H; Kitayoshi T; Sato S; Wakimasu M; Watanabe T; Fujino M
    Life Sci; 1994; 55(4):301-10. PubMed ID: 8028448
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Modulation of endothelin and nitric oxide: a rational approach to improve canine hepatic microcirculation.
    Dhar DK; Yamanoi A; Ohmori H; Nakashima Y; Yamamoto A; Osama NE; Kubota H; Kohno H; Nagasue N
    Hepatology; 1998 Sep; 28(3):782-8. PubMed ID: 9731573
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of endothelin receptor antagonist (TAK-044) on autotransplanted perfused kidneys in dogs.
    Yoshida K; Kagebayashi Y; Kitauchi T; Kimura S; Yoneda T; Ozono S; Hirao Y; Watanabe T
    Urol Int; 2000; 65(3):148-54. PubMed ID: 11054033
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of the acute effects of a selective endothelin ETA and a mixed ETA/ETB receptor antagonist in heart failure.
    Ohnishi M; Wada A; Tsutamoto T; Fukai D; Kinoshita M
    Cardiovasc Res; 1998 Sep; 39(3):617-24. PubMed ID: 9861304
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of an endothelin receptor antagonist and an angiotensin converting enzyme inhibitor on metabolism and contraction in the ischemic and reperfused rabbit heart.
    Kawabata H; Ryomoto T; Ishikawa K
    Jpn Circ J; 1999 Oct; 63(10):770-4. PubMed ID: 10553919
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Renoprotective effects of a combined endothelin type A/type B receptor antagonist in experimental malignant hypertension.
    Kohno M; Yokokawa K; Yasunari K; Kano H; Minami M; Ueda M; Tatsumi Y; Yoshikawa J
    Metabolism; 1997 Sep; 46(9):1032-8. PubMed ID: 9284892
    [TBL] [Abstract][Full Text] [Related]  

  • 17. An endothelin receptor antagonist ameliorates injuries of sinusoid lining cells in porcine liver transplantation.
    Fukunaga K; Takada Y; Mei G; Taniguchi H; Seino K; Yuzawa K; Otsuka M; Todoroki T; Goto K; Fukao K
    Am J Surg; 1999 Jul; 178(1):64-8. PubMed ID: 10456707
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Endothelin antagonist treatment for successful liver transplantation from non-heart-beating donors.
    Fukunaga K; Takada Y; Taniguchi H; Mei G; Seino KI; Yuzawa K; Otsuka M; Todoroki T; Goto K; Fukao K
    Transplantation; 1999 Jan; 67(2):328-32. PubMed ID: 10075603
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Role of endogenous endothelin in the extension of myocardial infarct size studied with the endothelin receptor antagonist, TAK-044.
    Kojima M; Kusumoto K; Fujiwara S; Watanabe T; Fujino M
    J Cardiovasc Pharmacol; 1995; 26 Suppl 3():S365-8. PubMed ID: 8587416
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Expression of endothelin-1 and effects of an endothelin receptor antagonist, TAK-044, at reperfusion after cold preservation in a canine lung transplantation model.
    Mizutani H; Minamoto K; Aoe M; Yamashita M; Date H; Andou A; Shimizu N
    J Heart Lung Transplant; 1998 Aug; 17(8):835-45. PubMed ID: 9730434
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.